752. Williams LS, et al. “Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke.” Neurology Volume 59, Pages 67-71. 2002. http://www.neurology.org/cgi/content/abstract/59/1/67
753. Ridker P and Samuel MA. “Inflammation and Neurological Disease.” Continuum, Volume 11, Issue 1, Pages 114-118. February 2005. http://www.aan.com/elibrary/continuum/?event=home.showIssue&issue=ovid.com:/issue/ovftdb/00132979-200502000-00000
754. Brinchmann-Hansen O, et al. “Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study.” British Medical Journal, Volume 304, Number 6818, Pages 19–22. January 4, 1992. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1880908
755. Aristedi R and Serafim K. “The Influence of Hyperglycemia on Neurological Outcome in Patients with Severe Head Injury.” Neurosurgery, Volume 46, Number 2, Pages 335, February 2000. http://www.neurosurgery-online.com/pt/re/neurosurg/abstract.00006123-200002000-00015.htm;jsessionid=HbJb6gYJnLlcwYrKt3C4W8s2V8Y8v2zGtNyfQspfwrPx1CDZcP01!-1288052477!181195628!8091!-1
756. Shaw CE, et al. “ALS: Progress in Pathogenesis.” Current Neurology and Neuroscience Reports. Volume 1, Number 1. February 2001. http://www.springerlink.com/content/55kt16rx1714q151/
757. Kato S, et al. “Astrocytic hyaline inclusions contain advanced glycation endproducts in familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutation: immunohistochemical and immunoelectron microscopical analyses.” Acta Neuropathologica. Volume 97, Number 3, Pages 260-6. March 1999. http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=10090673&dopt=AbstractPlus
758. Gao X, et al. “Erectile Function and Risk of Parkinson’s Disease.” American Journal of Epidemiology. Volume 166, Number 12, Pages 1446-1450. December 1, 2007. http://aje.oxfordjournals.org/cgi/content/abstract/166/12/1446?max…er&searchid=1&FIRSTINDEX=0&Volume=166&issue=12&resourcetype=HWCIT
759. Takamiya R, et al. “Glycation proceeds faster in mutated Cu, Zn-superoxide dismutases related to familial amyotrophic lateral sclerosis.” FASEB Journal. Published online March 5, 2003. http://www.fasebj.org/cgi/content/abstract/02-0768fjev1
760. Kieseier, BC and Hartung, H-P. “Multiple paradigm shifts in multiple sclerosis. Demyelinating diseases.” Current Opinion in Neurology. Volume 16, Number 3, Pages 247-252. June 2003. http://www.co-neurology.com/pt/re/coneuro/abstract.00019052-200306000-00001.htm;jsessionid=HVbCyt0kYpvDGXy1wJYjC9ZjzvHskSh2ttJR1919HLpfvqTq42hM!1717287316!181195628!8091!-1
761. Columbia University Health Science. “Multiple Sclerosis: Reducing RAGE. Blocking the RAGE Receptoer prevents multiple sclerosis symptoms in mice.” IN VOVO. Volume 2, Number 5. March 12, 2003. http://www.cumc.columbia.edu/news/in-vivo/Vol2_Iss05_mar12_03/index.html
762. Shibata N, et al. “Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.” Acta Neuropathologica. Volume 100, Number 3, Pages 275-284. July 2000. http://www.springerlink.com/content/ukpr2mvqyrn36pw3/
763. Kaufmanna, E, et al. “The advanced glycation end-product N -(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.” Neuroscience Letters. Volume 371, Issues 2-3, Pages 226-229. November 23, 2004. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T0G-4DDRB2C-3&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=6087df0af06bda5f8e4b52774a5dca88
764. Di Napoli M. “C-Reactive Protein and Acute Phase of Ischemic Stroke.” British Medical Journal. Volume 322, Page 1605. June 30, 2001. http://bmj.bmjjournals.com/cgi/content/full/322/7302/1605/a
765. VanItallie TB, et al. “Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study.” NEUROLOGY. Volume 64, Number 4, Pages 728-730. 2005. http://www.neurology.org/cgi/content/abstract/64/4/728
766. Sasaki N, et al. “Advanced Glycation End Products in Alzheimer’s Disease and Other Neurodegenerative Diseases.” American Journal of Pathology. Volume 153, Pages 1149–1155. 1998. http://ajp.amjpathol.org/cgi/reprint/153/4/1149.pdf
767. Chen H, et al. “Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease.” Archives of Neurology. Volume 60, Number 8, Pages 1059-1064. August 2003. http://archneur.ama-assn.org/cgi/reprint/60/8/1059
768. Freeman JM et al. “The Ketogenic Diet: One Decade Later.” PEDIATRICS. Volume 119, Number 3, Pages 535-543. March 2007. http://pediatrics.aappublications.org/cgi/content/abstract/119/3/535
769. Oh K, et al. “Carbohydrate Intake, Glycemic Index, Glycemic Load, and Dietary Fiber in Relation to Risk of Stroke in Women.” American Journal of Epidemiology. Volume 161, Number 2. Pages 161-169. 2005. http://aje.oxfordjournals.org/cgi/reprint/161/2/161.pdf
770. Yuki N, et al. “Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain–Barré syndrome.” Proceedings of the National Academy of Sciences of the United States of America. Volume 101, Number 31, Pages11404–11409. August 3, 2004. http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=509213&blobtype=pdf
771. NIHDDK. “Diabetic Neuropathies: The Nerve Damage of Diabetes.” National Diabetes Information Clearinghouse. http://diabetes.niddk.nih.gov/dm/pubs/neuropathies
772. Martino G, et al. “Inflammation in multiple sclerosis: the good, the bad, and the complex.” The Lancet Neurology. Volume 1, Number 8. December 1, 2002. http://www.mult-sclerosis.org/news/Nov2002/FullTextInflammationinMS.html#abstract
773. Orr AA. “Inflammation is key to ALS.” From the Laboratories. Volume 2, Issue 7. July 2003. http://www.bcm.edu/fromthelab/vol02/is7/03july_n2.htm
774. Vila N, et al. “Levels of Anti-Inflammatory Cytokines and Neurological Worsening in Acute Ischemic Stroke.” Stroke. Volume 34, Pages 671-675. 2003. http://stroke.ahajournals.org/cgi/content/full/34/3/671
775. Sandyk R. “The relationship between diabetes mellitus and Parkinson’s disease.” International Journal of Neuroscience. Volume 69, Issue 1-4, Pages 125-30. March-April 1993. http://www.informaworld.com/smpp/content~content=a783403990~db=all
776. Carnethon MR, et al. “The Association Among Autonomic Nervous System Function, Incident Diabetes, and Intervention Arm in the Diabetes Prevention Program.” DIABETES CARE. Volume 29, Number 4, Pages 914–919. APRIL 2006. http://care.diabetesjournals.org/cgi/content/full/29/4/914
777. Pop-Busui R, et al. “Sympathetic dysfunction in type 1 diabetes: Association with impaired myocardial blood flow reserve and diastolic dysfunction.” Journal of the American College of Cardiology, Volume 44, Pages 2368-2374. 2004. http://content.onlinejacc.org/cgi/content/figsonly/44/12/2368
778. Gillman MW, et al. “Inverse association of dietary fat with development of ischemic stroke in men.” Journal of American Medical Association. Volume 278, Number 24, Pages 2145-50. Dec 24-31, 1997. http://jama.ama-assn.org/cgi/content/abstract/278/24/2145
779. Huang X, et al. “Lower low-density lipoprotein cholesterol levels are associated with Parkinson’s disease.” Movement Disorders. Volume 22, Number 3, Pages 377-381. February 15, 2007. http://www.ncbi.nlm.nih.gov/pubmed/17177184
780. Sauvaget C, et al. “Animal Protein, Animal Fat, and Cholesterol Intakes and Risk of Cerebral Infarction Mortality in the Adult Health Study.” Stroke. Volume 35, Pages 1531-1537. 2004. http://stroke.ahajournals.org/cgi/content/full/35/7/1531
781. Cooper LS, et al. “Retinal Microvascular Abnormalities and MRI-Defined Subclinical Cerebral Infarction.” Stroke. Volume 37, Pages 82-86. 2006. http://stroke.ahajournals.org/cgi/content/full/strokeaha;37/1/82
782. Swink TD, ET AL. “The ketogenic diet: 1997.” Advances in Pediatrics. Volume 44, Pages 297-329. 1997. http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=9265974&dopt=Citation
783. Hemingway C, et al. “The Ketogenic Diet: A 3- to 6-Year Follow-Up of 150 Children Enrolled Prospectively.” Pediatrics. Volume 108, Pages 898-905. 2001. http://pediatrics.aappublications.org/cgi/content/full/108/4/898
784. Yudkoff M, et al. “The Ketogenic Diet and Brain Metabolism of Amino Acids: Relationship to the Anticonvulsant Effect.” Annual Reviews. Volume 27, Pages 415-430. August 2007. http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.nutr.27.061406.093722?journalCode=nutr
785. Huang X, et al. “Lower low density lipid cholesterol levels are associated with Parkinson’s disease.” Movement Disorder. 2007 February 15; 22(3): 377–381. http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1906875&blobtype=pdf
786. de Lau LML, et al. “Serum Cholesterol Levels and the Risk of Parkinson’s Disease.” American Journal of Epidemiology. Volume 164, Number 10, Pages 998-1002. 2006. http://aje.oxfordjournals.org/cgi/reprint/164/10/998
787. Berne C, et al. “Sympathetic response to oral carbohydrate administration. Evidence from microelectrode nerve recordings.” Journal of Clinical Investigation, Volume 84, Number 5, Pages 1403–1409. November 1989. http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=304002&blobtype=pdf
788. Yoon SS and Zheng Z-J. “Elevated total white blood cell count with high blood glucose is associated with poor outcome after ischemic stroke.” Journal of Stroke and Cerebrovascular Diseases. Volume 14, Issue 2, Pages 88-93. March-April 2005. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WM4-4FMHP3D-D&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=73297760fb08d5df94e67a0b396295db
789. Elkind MS, et al. “Elevated White Blood Cell Count and Carotid Plaque Thickness: The Northern Manhattan Stroke Study.” Stroke. Volume 32, Pages 842-849. 2001. http://stroke.ahajournals.org/cgi/content/full/32/4/842
790. Kimura K, et al. “Hyperglycemia independently increases the risk of early death in acute spontaneous intracerebral hemorrhage.” Journal of the Neurological Sciences. Volume 255, Issues 1-2, Pages 90-94. April 15, 2007, http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T06-4N7RDKK-4&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=47fc358677789f9521c79abbc1a653c8
791. Capes SE, et al. “Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients. A Systematic Overview.” Stroke. Volume 32, Pages 2426-2432. 2001. http://stroke.ahajournals.org/cgi/reprint/32/10/2426.pdf
Previous | Study Guide | Next
